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PyroTyping, a novel 
pyrosequencing-based assay 
for Mycobacterium tuberculosis 
genotyping
B. Molina-Moya1,3, A. Lacoma1,3, N. García-Sierra1, S. Blanco1,3, L. Haba1, S. Samper3,4,5,  
J. Ruiz-Manzano2,3, C. Prat1,3, C. Arnold6 & J. Domínguez1,3
We developed a novel method, PyroTyping, for discrimination of Mycobacterium tuberculosis isolates 
combining pyrosequencing and IS6110 polymorphism. A total of 100 isolates were analysed with 
IS6110-restriction fragment length polymorphism (RFLP), spoligotyping, mycobacterial interspersed 
repetitive units – variable number tandem repeats (MIRU-VNTR), and PyroTyping. PyroTyping results 
regarding clustering or discrimination of the isolates were highly concordant with the other typing 
methods performed. PyroTyping is more rapid than RFLP and presents the same discriminatory power, 
thus, it may be useful for taking timely decisions for tuberculosis control.
Tuberculosis (TB) is one of the leading causes of death among curable infectious diseases, and worldwide spread 
of Mycobacterium tuberculosis isolates, the causative agent, poses a threat to the global control of TB1. In order 
to improve TB control, it is important to track the spread of M. tuberculosis isolates, identify index cases, and 
detect outbreaks. For these purposes, several genotyping methods have been developed2. Some of these methods 
are based on the polymorphism of copy number and location of the insertion sequence (IS 6110. The most used 
IS6110-based genotyping method is restriction fragment length polymorphism (RFLP)3. However, RFLP is labo-
rious and time-consuming, thus, the time until results are available may be too long for decision-making. Another 
extensively used genotyping method is spoligotyping4, based on the polymorphism of the clustered regularly 
interspaced short palindromic repeats (CRISPR) locus in the M. tuberculosis genome. Although spoligotyping 
is more rapid and easy to perform than RFLP, it presents a lower discriminatory power2. Finally, the molecular 
typing method considered as gold standard is the mycobacterial interspersed repetitive units - variable number 
of tandem repeats (MIRU-VNTR), based on the polymorphism of number of the repeats in 24 loci in the M. 
tuberculosis genome2. However, the different protocols for this method are either expensive (fluorescence-based 
sequencing) or time consuming (gel electrophoresis). Hence, new rapid, simple, and discriminatory methods for 
molecular epidemiology studies could be useful.
The aim of the present study was to develop a novel molecular method based on PCR amplification and 
pyrosequencing (PyroTyping) for discrimination of isolates based on the polymorphism of the IS6110 insertion 
site. In addition, PyroTyping results regarding clustering or discrimination of the isolates were compared with 
RFLP, spoligotyping, and 24-loci MIRU-VNTR results.
The PyroTyping assay (Fig. 1) consists of digestion of the M. tuberculosis genomic DNA with TaqI restriction 
enzyme, which cuts on a target located within the IS6110 and in a target located 5′ to the IS6110, dependent on 
insertion point; ligation of adaptors; touchdown PCR for amplification of the 5′ IS6110-flanking region of all the 
IS6110 copies present in the genome; and simultaneous pyrosequencing of the amplified fragments. When two 
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isolates share the same RFLP pattern, the IS6110 copies are located in the same position in the genome, and thus, 
the sequence of the IS6110-5′ flanking regions would be identical. In this case, pyrosequencing profiles would also 
be identical. On the contrary, when two isolates exhibit different RFLP patterns, pyrosequencing profiles would 
also be different. The PyroTyping assay was shown to be reproducible in the three independent reactions per-
formed using DNA extracted from the M. tuberculosis reference strain H37Rv. In addition, the limit of detection 
was set at 100 ng of DNA.
The PyroTyping assay was performed in a set of 100 M. tuberculosis isolates: 94 isolates corresponded to 29 
molecular epidemiology case studies that were part of standard investigations of contact tracing or suspected 
cases of laboratory cross-contamination (Table 1), and the remaining six isolates were multidrug-resistant 
(MDR) isolates from patients from different countries (two patients from Morocco, two from Romania, one from 
Colombia, and one from Spain) for which there was not known or suspected link. RFLP and spoligotyping were 
performed for all the isolates, and MIRU-VNTR was performed for the 86 isolates for which DNA was available 
(78 isolates corresponding to 24 case studies and the six MDR isolates).
Results between RFLP, spoligotyping, and PyroTyping for the 100 M. tuberculosis isolates were concordant: 
the three methods agreed on clustering for 74 isolates (Fig. 2a), and on discrimination for 26 isolates (Fig. 2b) 
(Table 1). Results of MIRU-VNTR were concordant with the other methods except in three cases (Table 2). In 
addition, slight variations in the RFLP and/or the MIRU-VNTR patterns were detected in three case studies 
(Table 2). Spoligotyping and MIRU-VNTR patterns are available as Supplemental Material.
Among the 100 isolates, 11 isolates had a low IS6110 copy number (considered as six or fewer bands in the 
RFLP pattern2). These 11 isolates corresponded to four case studies (case studies 2, 7, 14, and 26) involving 3, 5, 
2 and 2 isolates, respectively (one isolate had a high IS6110 copy number). The three isolates of case study 2 were 
clustered by RFLP (one band), spoligotyping (SIT334, T1), and PyroTyping, but MIRU-VNTR could not be per-
formed. Regarding the five isolates of case study 7, four isolates were those described in Table 2, whereas the other 
isolate presented a different RFLP pattern (three bands), spoligotyping (SIT326, AFRI_1), MIRU-VNTR, and 
PyroTyping profile. The two isolates of case study 26 were clustered by RFLP (three bands), spoligotyping (SIT41, 
LAM7-TUR), MIRU-VNTR, and PyroTyping. The two isolates of case study 14 presented different RFLP patterns 
Figure 1. Schematic diagram of the PyroTyping assay. Genomic DNA of M. tuberculosis isolates grown in 
Löwenstein-Jensen solid medium was extracted by the cetyltrimethylammonium bromide protocol. After, DNA 
was digested with Tru1I (MseI) and TaqI restriction enzymes (note that the arrows no dot represent the exact 
restriction sites) (a); adaptors were ligated to the TaqI restricted fragments (b); the fragments were amplified by 
PCR using a biotinylated primer complementary to the adaptor and a primer complementary to the IS6110 (c); 
finally, the amplification product was subjected to pyrosequencing of the 5′ IS6110-flanking regions by using a 
primer complementary to the 5′ end of the IS6110 (d).
Type of investigation
No. of case studies 
(no. of isolates)
No. of patients in each case study  
(no. of patient isolates clustered by RFLP)
Contact tracing 22 (72)
Family members 9 (23) 3 (3), 2 (2), 3 (3), 2 (2a), 2 (2), 4 (4), 3 (3), 2 (2), 2 (2)
Spatio-temporal proximity 5 (32) 15 (4, 2, 2, 2), 5 (5), 2 (0), 8 (8b), 2 (2b)
Cohabitants 3 (7) 3 (2), 2 (2), 2 (0)
Workplace 4 (8) 2 (0), 2 (0), 2 (2), 2 (2)
Friends 1 (2) 2 (0)
Laboratory cross-contamination 7 (22) 3 (3), 3 (2), 6 (4), 2 (2), 3 (2), 3 (3), 2 (2)
Table 1. Case studies of molecular epidemiology investigations. aOne of the isolates within the cluster 
presented two additional bands in RFLP. bOne of the isolates within the cluster presented an additional band in 
RFLP. RFLP: restriction fragment length polymorphism.
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(five and nine bands, respectively), spoligotyping (SIT42, LAM9; SIT160, clade not assigned), MIRU-VNTR, and 
PyroTyping profiles.
Genotyping of M. tuberculosis isolates is a valuable tool for TB control and has improved knowledge about TB 
epidemiology2, 5. The most widely used method based on IS6110 has been RFLP, but it presents limitations for 
taking rapid decisions for TB control. To overcome these disadvantages, different rapid genotyping assays based 
on PCR and the polymorphism of IS6110 have been developed. Some of these methods are based on DNA diges-
tion with restriction enzymes, ligation of adaptors, PCR amplification, and analysis of the amplified fragments. 
The most used and improved assays have been ligation-mediated PCR6, 7 and mixed-linker PCR8, 9. Most of 
these methods perform a gel electrophoresis after PCR, and the fingerprint patterns obtained may display a low 
number of bands, which limits the level of discrimination that may be achieved. In contrast, in the PyroTyping 
assay we carried out a touchdown PCR for specific and efficient amplification of the IS6110 5′-flanking regions, 
followed by pyrosequencing, which yields a pyrogram with a variable number of nucleotide peaks, allowing bet-
ter discrimination compared to the limited number of bands of a gel electrophoresis. In fact, there was complete 
Figure 2. Examples of spoligotyping, IS6110-RFLP, 24-loci MIRU-VNTR, and PyroTyping results for some 
of the M. tuberculosis isolates included in this study. (a) Results for isolates sharing the same spoligotyping, 
IS6110-RFLP, 24-loci MIRU-VNTR, and PyroTyping profiles. (b) Results for isolates showing different 
spoligotyping, IS6110-RFLP, 24-loci MIRU-VNTR, and PyroTyping profiles. RFLP: restriction fragment length 
polymorphism. MIRU-VNTR: mycobacterial interspersed repetitive units - variable number of tandem repeats.
Case study No. of isolates RFLP result Spoligotyping result MIRU-VNTR result PyroTyping result
7 4 Clustered Clustered Clustered Clustered
(5 bands) (pattern not described in SITVITWEB) (one isolate with 1 different locus)
12 2 Clustered Clustered Clustered Clustered
(15 bands and 17 bands) (pattern not described in SITVITWEB)
17 5 Clustered Clustered Clustered Clustered
(9 bands) (SIT53, T1) (1 different locusa)
19 2 Discriminated Discriminated Clustered Discriminated
(8 bands and 10 bands) (SIT58, T5-Madrid2; SIT33, LAM3)
28 8 Clustered Clustered Discriminated Clustered
(seven isolates with 10 bands, 
one isolate with 11 bands) (pattern not described in SITVITWEB) (4 different loci)
29 2 Clustered Clustered Discriminated Clustered
(9 bands and 10 bands) (SIT53, T1) (7 different loci)
Table 2. Clustering and discrimination results of RFLP, spoligotyping, MIRU-VNTR, and PyroTyping for 
the isolates showing variations in the RFLP and/or the MIRU-VNTR patterns. aOne isolate had 3 repeats, 
two isolates had 6 repeats, and two isolates had more than 15 repeats. RFLP: restriction fragment length 
polymorphism. MIRU-VNTR: mycobacterial interspersed repetitive units - variable number of tandem repeats.
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concordance between PyroTyping and RFLP, hence, when PyroTyping profiles are the same, the isolates can be 
certainly clustered, and vice versa. Furthermore, direct analysis of patient specimens with PyroTyping will be set 
up, upon optimization of the protocol, in order to obtain enough double stranded high-quality DNA required 
for digestion.
The four typing methods performed in this study showed major discrepancies regarding the clustering or 
discrimination of the isolates in three case studies, mainly attributed to MIRU-VNTR. In one case, the two iso-
lates were discriminated by RFLP, spoligotyping, and PyroTyping, but clustered by MIRU-VNTR. In the other 
two cases, the respective eight and two isolates were clustered by RFLP, spoligotyping, and PyroTyping, but 
one of the isolates in each case presented an additional band in RFLP, and the MIRU-VNTR patterns differed 
from the other isolates in three and seven loci, respectively. This may be explained by a higher discriminatory 
power of MIRU-VNTR. In addition, in other three case studies, although the isolates were clustered by the four 
typing methods, slight variations in the RFLP (one or two additional bands) and/or the MIRU-VNTR patterns 
(a different number of repeats in one loci) were detected. There has been some controversy on considering or 
not as being part of the same cluster isolates with those slightly different RFLP patterns2, 10, since RFLP profiles 
of isolates from a single source may differ in the presence or absence of at least one band11. In the same line, 
isolates with known epidemiological links and clustered by RFLP but showing single-locus variations in the 
MIRU-VNTR patterns have been reported12, 13. In the present study, we considered that these isolates were 
clustered because patients within case studies were epidemiologically related, isolates from related patients 
may present these minor changes14, the rate of transposition increases with the number of copies of IS6110 2, 
and the degree of clonality with MIRU-VNTR typing is high15. For those isolates that differed by one or two 
bands in the RFLP, the PyroTyping profiles were similar, and thus, the isolates were considered to be clustered 
by PyroTyping. It is of note that the height of some peaks in the pyrograms were slightly different, which may be 
the reflect of an additional sequence corresponding to the extra IS6110 copy. However, the current accuracy of 
the method does not allow quantifying the exact number of nucleotides corresponding to the peak heights for 
subsequent comparison of isolates. In conclusion, the molecular relatedness of the isolates within case studies 
was supported by the different typing methods, although slightly more information was obtained by RFLP and 
MIRU-VNTR.
A drawback of IS6110-based genotyping methods is the reduced discriminatory power for low IS6110 copy 
number isolates. RFLP clusters involving these isolates should be discriminated by another genotyping method 
not based on IS6110. Since PyroTyping is based on IS6110, it will not be informative for these isolates. However, 
in the present study, RFLP results regarding low IS6110 copy number isolates were concordant with spoligotyping 
and MIRU-VNTR, and also with PyroTyping results. Variations of the method based on other repetitive elements 
present would be easily developed along the same lines reported here.
The PyroTyping assay can be performed in two days, the first day for digestion and ligation procedures, and 
the second one for PCR and pyrosequencing reaction. The overall procedure requires moderate training, espe-
cially for preparing the pyrosequencing reaction. In addition, PyroTyping requires specific equipment (pyrose-
quencer), but can be performed in 96-well plates, for high-throughput analysis, with a cost of reagents around 
20USD per sample. Furthermore, PyroTyping profiles of the isolates within each case study were compared by 
the naked eye, therefore, the interpretation does not require a complex bioinformatics analysis, but for now it is 
restricted to a limited number of isolates with a suspected link. However, with a comprehensive software tool for 
storage and comparison of the PyroTyping profiles, a database for M. tuberculosis isolates from a geographical 
setting could be created, for clinical as well as for epidemiological purposes. In addition, upon optimization of 
the methodology, PyroTyping could be performed directly from clinical specimens. Moreover, since pyrose-
quencing has been used for detecting mutations associated with drug resistance16, 17, genotyping and detection of 
drug resistance could be performed in a combined assay, further increasing the clinical value of the technology 
for patient management. Lastly, the PyroTyping assay is potentially applicable for genotyping other bacterial 
species presenting polymorphism of insertion sequences, such as Salmonella typhimurium or Staphylococcus 
aureus18, 19.
In conclusion, we have developed PyroTyping, a novel, rapid, and highly discriminatory assay that offers a 
promising alternative for M. tuberculosis genotyping for epidemiological studies in local and reference laborato-
ries. The introduction of the touchdown PCR and pyrosequencing improved the performance over other methods 
analysing the variability on the flanking regions of the IS6110 elements.
Methods
Clinical strains. During the period from 2006 to 2014, a total of 100 M. tuberculosis isolates were retrospec-
tively selected. The isolates were received from different local clinical laboratories in Catalunya or were isolated 
in Hospital Universitari Germans Trias i Pujol. Almost one third of the patients were immigrants from differ-
ent countries with high incidence of tuberculosis (Romania, Georgia, Morocco, Senegal, Mali, Gambia, Peru, 
Dominican Republic). Ninety-four of the 100 isolates corresponded to 29 molecular epidemiology case studies 
that were part of standard contact tracing investigations or suspected cases of laboratory cross-contamination 
(Table 1). The remaining six isolates were multidrug-resistant (MDR) M. tuberculosis isolates from patients from 
different countries (two patients from Morocco, two from Romania, one from Colombia, and one from Spain) for 
which there was not known or suspected link. All the isolates were subcultured on Löwenstein-Jensen (LJ) solid 
medium for at least four weeks or until colonies were well grown. All methods were carried out in accordance 
with relevant guidelines and regulations. This study was approved by the ethics committee in Institut Germans 
Trias i Pujol. Informed consent was obtained from all subjects.
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RFLP and spoligotyping. RFLP and spoligotyping were the routine molecular typing methods performed 
in Hospital Universitari Germans Trias i Pujol during the time of the study. DNA was extracted from isolates 
cultured on LJ following the cetyltrimethylammonium bromide (CTAB) protocol20. RFLP was performed as pre-
viously described3. Table 1 shows the molecular epidemiology investigation case studies, with the number of 
patients in each case study and the number of patient isolates clustered by RFLP.
Spoligotyping was performed using the spoligokit (Ocimum Biosolutions, Hyderabad, India) following the 
manufacturer’s instructions. The individual spoligotyping patterns were compared with those in the International 
Spoligotyping Database (SITVITWEB) of the Pasteur Institute of Guadeloupe, (http://www.pasteur-guadeloupe.
fr:8081/SITVIT_ONLINE/). Spoligotyping International Types (SIT) were assigned according to spoligotype 
pattern signatures provided in SITVITWEB. Following the routine procedures, when RFLP and spoligotyping 
patterns were identical, isolates were considered to be clustered, whereas when patterns of RFLP and/or spoligo-
typing were different, isolates were considered to be unrelated. It is of note that RFLP patterns with a high number 
of bands that differed only in one or two bands were considered to be clustered10, 14.
24-loci MIRU-VNTR. Among the 100 M. tuberculosis isolates included in the study, 24-loci MIRU-VNTR 
was performed for the 86 isolates for which DNA was available. 24-loci MIRU-VNTR typing was performed using 
a quadriplex PCR provided in a commercial kit (Genoscreen, Lille, France) and processed with a 48-capillary 
ABI 3730 DNA Analyzer (Applied Biosystems, CA, USA). For MIRU-VNTR allele assignation GeneMapper 
software (Applied Biosystems, CA, USA) was used21. Genotyping was performed at the Laboratory of Molecular 
Epidemiology of Mycobacteria in Fundacion IIS Aragon, Zaragoza, Spain.
PyroTyping. PyroTyping is a genotyping method based on the polymorphism of IS6110 (Fig. 1). It con-
sists of digestion of the M. tuberculosis genomic DNA with TaqI restriction enzyme, which cuts in a target 
(T^CGA) located within the IS6110 and in a target located 5′ to the IS6110, dependent on insertion point; 
ligation of adaptors; touchdown PCR for amplification of the 5′ IS6110-flanking region of all the IS6110 cop-
ies present in the genome; and simultaneous pyrosequencing of the amplified fragments. When two isolates 
share the same RFLP pattern, the IS6110 copies are located in the same position in the genome, and thus, the 
sequence of the IS6110-5′ flanking regions would be identical. In this case, pyrosequencing profiles would be 
identical. On the contrary, when two isolates exhibit different RFLP patterns, pyrosequencing profiles would 
be different.
A first genomic digestion was performed in a final volume of 20 µl containing 5U Tru1I (MseI) (Thermo 
Fisher Scientific, Waltham, MA, USA), 1X Tru1I buffer R (Thermo Fisher Scientific, Waltham, MA, USA), 0.1 mg/
mL bovine serum albumin (BSA) (Hoffmann-La Roche, Basel, Switzerland), 0.5 mg/mL DNase-free RNase A 
(Hoffmann-La Roche, Basel, Switzerland), and 500 ng of CTAB-extracted genomic DNA. The Tru1I (MseI) 
digestion was carried out at 37 °C for at least 2 h. This digestion was performed in order to obtain smaller DNA 
fragments and facilitate the TaqI activity. A second digestion was performed by addition of 10U TaqI (Thermo 
Fisher Scientific, Waltham, MA, USA), and incubation at 65 °C for 3 h, and 80 °C for 2 min. Subsequently, a 
24.6 µl ligation mix containing 40U of T4 DNA ligase (New England Biolabs, Ipswich, MA, USA), 2X T4 ligase 
buffer (Hoffmann-La Roche, Basel, Switzerland), and 0.2 µM of each adaptor (5′-CGGTCAGGACTCAT-3′, 
5′-CGATGAGTCCTGAC-3′) (TIB MOLBIOL, Berlin, Germany) was added to the digestion product. Ligation 
was carried out at 12 °C for 17 h, and 65 °C for 10 min.
Touchdown PCR22 was performed in a final volume of 25 µl containing 1X HotStarTaq Master Mix 
(Qiagen, Venlo, The Netherlands), 1 µM each primer (forward 5′biotin-ATGAGTCCTGACCGA-3, reverse 
5′-CTGACATGACCCCATCCTTT-3′) (TIB MOLBIOL, Berlin, Germany), 1 M betaine PCR reagent 
(Sigma-Aldrich, St. Louis, MO, USA), and 2.5 µl of ligation product. Touchdown PCR was carried out with the 
Veriti thermal cycler (Applied Biosystems, Foster City, CA, USA) and the following amplification conditions: 
94 °C for 15 min; 10 cycles of 94 °C for 20 s, 66–56 °C for 30 s (temperature decreasing 1 °C every cycle from 
66 °C to 56 °C), and 72 °C for 2 min; 20 cycles of 94 °C for 20 s, 56 °C for 30 s, and 72 °C for 2 min; and 72 °C for 
7 min. Finally, pyrosequencing of the PCR product was performed using a PSQ 96MA and SQA software as 
recommended by the manufacturer (Qiagen, Venlo, The Netherlands). Briefly, the protocol consisted in the 
preparation of the single-stranded DNA with a vacuum preparation tool, annealing of the sequencing primer 
(5′-GGACATGCCGGGGCGGTT-3′) (TIB MOLBIOL, Berlin, Germany), and real-time pyrosequencing. In 
this protocol, the nucleotide dispensation order was 7x(ACTG), thus, the pyrograms presented 28 nucleotide 
peaks.
The result for each isolate consisted of a single pyrogram combining the simultaneous pyrosequencing of the 
5′ flanking regions of all the IS6110 copies present in the genome (Fig. 2). Therefore, the pyrogram corresponds 
to an artificial sequence obtained from the merged sequences of all the 5′ flanking regions. PyroTyping profiles 
from isolates from each case study were compared by the naked eye. When the same PyroTyping profiles were 
obtained, isolates were considered to be clustered, whereas when PyroTyping profiles were different, isolates were 
considered to be discriminated. Clustering or discrimination results obtained by PyroTyping were compared with 
those obtained by RFLP and spoligotyping. Spoligotyping and RFLP results were blinded to the researchers who 
interpreted PyroTyping results.
To assess the reproducibility of PyroTyping, three independent reactions were performed using DNA 
extracted from the M. tuberculosis reference strain H37Rv. In addition, to assess the limit of detection of the assay, 
six additional reactions were performed using ten-fold serial dilutions of DNA extracted from H37Rv (100ng to 
0.001ng).
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Data Availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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